Global Antimicrobial Therapeutics Market 2020-2024

Global Antimicrobial Therapeutics Market 2020-2024

Technavio has been monitoring the antimicrobial therapeutics market and it is poised to grow by $ 42.30 million during 2020-2024 progressing at a CAGR of 6% during the forecast period. Our reports on antimicrobial therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the recent drug approvals and robust pipeline, initiatives from government agencies, and rising awareness about microbial diseases. In addition, recent drug approvals and robust pipeline is anticipated to boost the growth of the market as well.

The antimicrobial therapeutics market analysis includes application segment and geographic landscapes

Technavio's antimicrobial therapeutics market is segmented as below:

By Application

  • Antiviral
  • Antibacterial
  • Antifungal
  • Antiparasitic
By Geographic Landscapes
  • North America
  • Europe
  • APAC
  • ROW
This study identifies the increase in R&D of therapeutic vaccines as one of the prime reasons driving the antimicrobial therapeutics market growth during the next few years. Also, increased disease diagnostic modalities, and increasing research on combination therapies will lead to sizable demand in the market.

"Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our antimicrobial therapeutics market covers the following areas:
  • Antimicrobial therapeutics market sizing
  • Antimicrobial therapeutics market forecast
  • Antimicrobial therapeutics market industry analysis
"

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antimicrobial therapeutics market vendors that include AbbVie Inc., CSL Ltd., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pfizer Inc., and Sanofi. Also, the antimicrobial therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.


  • Executive Summary
  • Market Landscape
    • Market ecosystem
      • Table Parent market
      • Table Market characteristics
    • Value chain analysis
      • Table Value chain analysis: Pharmaceuticals
      • Research and development (R&D) and drug discovery:
      • Integration and product development:
      • Manufacturing:
      • Outbound logistics:
      • Marketing and sales:
      • Support services:
  • Market Sizing
    • Market definition
      • Table Offerings of vendors included in the market definition
    • Market segment analysis
      • Table Market segments
    • Market size 2019
    • Market outlook: Forecast for 2019 - 2024
      • Table Global - Market size and forecast 2019-2024 ($ million)
      • Table Global Antimicrobial Therapeutics Market 2020-2024 ($ million), exclusive of Covid-19 impact
      • Table Global market: Year-over-year growth 2019-2024 (%)
  • Five Forces Analysis
    • Five forces summary
      • Table Five forces analysis 2019 & 2024
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2019
  • Market Segmentation by Application
    • Market segments
      • Table Application - Market share 2019-2024 (%)
    • Comparison by Application
      • Table Comparison by Application
    • Antiviral - Market size and forecast 2019-2024
      • Table Antiviral - Market size and forecast 2019-2024 ($ million)
      • Table Global antimicrobial market for Antiviral 2019-2024 - Market Size ($ million) exclusive of COVID-19 impact
      • Table Antiviral - Year-over-year growth 2019-2024 (%)
    • Antibacterial - Market size and forecast 2019- 2024
      • Table Antibacterial - Market size and forecast 2019-2024 ($ million)
      • Table Global antimicrobial market for Antibacterial 2019-2024 - Market Size ($ million) exclusive of COVID-19 impact
      • Table Antibacterial - Year-over-year growth 2019-2024 (%)
    • Antifungal - Market size and forecast 2019-2024
      • Table Antifungal - Market size and forecast 2019-2024 ($ million)
      • Table Global antimicrobial market for Antifungal 2019-2024 - Market Size ($ million) exclusive of COVID-19 impact
      • Table Antifungal - Year-over-year growth 2019-2024 (%)
    • Antiparasitic - Market size and forecast 2019- 2024
      • Table Antiparasitic - Market size and forecast 2019-2024 ($ million)
      • Table Global antimicrobial market for Antiparasitic 2019-2024 - Market Size ($ million) exclusive of COVID-19 impact
      • Table Antiparasitic - Year-over-year growth 2019-2024 (%)
    • Market opportunity by Application
      • Table Market opportunity by Application
  • Customer Landscape
    • Table Customer landscape
  • Geographic Landscape
    • Geographic segmentation
      • Table Market share by geography 2019-2024 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2019- 2024
      • Table North America - Market size and forecast 2019-2024 ($ million)
      • Table Global antimicrobial market in North America 2019-2024 - Market Size ($ million) exclusive of COVID-19 impact
      • Table North America - Year-over-year growth 2019-2024 (%)
    • Europe - Market size and forecast 2019-2024
      • Table Europe - Market size and forecast 2019-2024 ($ million)
      • Table Global antimicrobial market in Europe 2019-2024 - Market Size ($ million) exclusive of COVID-19 impact
      • Table Europe - Year-over-year growth 2019-2024 (%)
    • APAC - Market size and forecast 2019-2024
      • Table APAC - Market size and forecast 2019-2024 ($ million)
      • Table Global antimicrobial market in APAC 2019-2024 - Market Size ($ million) exclusive of COVID-19 impact
      • Table APAC - Year-over-year growth 2019-2024 (%)
    • ROW - Market size and forecast 2019-2024
      • Table ROW - Market size and forecast 2019-2024 ($ million)
      • Table Global antimicrobial market in ROW 2019-2024 - Market Size ($ million) exclusive of COVID-19 impact
      • Table ROW - Year-over-year growth 2019-2024 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity by geography
      • Table Market opportunity by geography ($ million)
  • Drivers, Challenges, and Trends
    • Volume driver – Demand led growth
      • Recent drug approvals and robust pipeline
        • Table Recent drug approvals
    • Volume driver – External factors
      • Initiatives from government agencies
      • Rising awareness about microbial diseases
    • Market challenges
      • Increased availability of generic drugs
      • Challenges associated with development, storage, and handling of vaccines
      • Rising antimicrobial resistance
        • Table Impact of drivers and challenges
    • Market trends
      • Increase in R&D of therapeutic vaccines
      • Increased disease diagnostic modalities
      • Increasing research on combination therapies
        • Table New combination therapies
  • Vendor Landscape
    • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
      • Table Industry risks
  • Vendor Analysis
    • Vendors covered
      • Table Vendors covered
    • Market positioning of vendors
      • Table Market positioning of vendors
    • AbbVie Inc.
      • Table AbbVie Inc. - Overview
      • Table AbbVie Inc. - Business segments
      • Table AbbVie Inc.- Key news
      • Table AbbVie Inc. - Key offerings
    • CSL Ltd.
      • Table CSL Ltd. - Overview
      • Table CSL Ltd. - Business segments
      • Table CSL Ltd. - Key news
      • Table CSL Ltd. - Key offerings
      • Table CSL Ltd. - Segment focus
    • F. Hoffmann-La Roche Ltd.
      • Table F. Hoffmann-La Roche Ltd. - Overview
      • Table F. Hoffmann-La Roche Ltd. - Business segments
      • Table F-Hoffmann-La Roche Ltd.- Key news
      • Table F. Hoffmann-La Roche Ltd. - Key offerings
      • Table F. Hoffmann-La Roche Ltd. - Segment focus
    • Gilead Sciences Inc.
      • Table Gilead Sciences Inc. - Overview
      • Table Gilead Sciences Inc. - Product and service
      • Table Gilead Sciences Inc. - Key news
      • Table Gilead Sciences Inc. - Key offerings
    • GlaxoSmithKline Plc
      • Table GlaxoSmithKline Plc - Overview
      • Table GlaxoSmithKline Plc - Business segments
      • Table GlaxoSmithKline Plc - Key news
      • Table GlaxoSmithKline Plc - Key offerings
      • Table GlaxoSmithKline Plc - Segment focus
    • Johnson & Johnson
      • Table Johnson & Johnson - Overview
      • Table Johnson & Johnson - Business segments
      • Table Johnson & Johnson - Key news
      • Table Johnson & Johnson - Key offerings
      • Table Johnson & Johnson - Segment focus
    • Merck & Co. Inc.
      • Table Merck & Co. Inc. - Overview
      • Table Merck & Co. Inc. - Business segments
      • Table F-Hoffmann-La Roche Ltd.- Key news
      • Table Merck & Co. Inc. - Key offerings
      • Table Merck & Co. Inc. - Segment focus
    • Novartis AG
      • Table Novartis AG - Overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Key news
      • Table Novartis AG - Key offerings
      • Table Novartis AG - Segment focus
    • Pfizer Inc.
      • Table Pfizer Inc. - Overview
      • Table Pfizer Inc. - Business segments
      • Table Pfizer Inc.- Key news
      • Table Pfizer Inc. - Key offerings
      • Table Pfizer Inc. - Segment focus
    • Sanofi
      • Table Sanofi - Overview
      • Table Sanofi - Business segments
      • Table Sanofi - Key news
      • Table Sanofi - Key offerings
      • Table Sanofi - Segment focus
  • Appendix
    • Scope of the report
      • Market definition
      • Objectives
      • Notes and caveats
    • Currency conversion rates for US$
      • Table Currency conversion rates for US$
    • Research methodology
      • Table Research Methodology
      • Table Validation techniques employed for market sizing
      • Table Information sources
    • List of abbreviations
      • Table List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook